Contact:

Dr. Agnes P. Olszewski
Phone: (201) 647-3757

Herborium Grows its Management Team with Industry Experts

Teaneck, New Jersey, May 1, 2007 Herborium Group, Inc. (OTCBB: HBRM), a developer and marketer of novel botanical therapeutics^®, including successful Acne and Rosacea treatment(www.acnease.com) announced today that it has appointed Mr. Daniel Teo as Senior Vice President of Business Development, and Mr. Lloyd Sems as Financial Advisor to its management team.

Mr. Teo brings 20 years of business development experience to the company. He is the former Vice President of Strategy, Planning and Corporate Affairs for British Petroleum (“BP”) in the Asia-Pacific, and BP’s Chief Financial Officer for its US East Coast business. He also served as BP’s Senior Strategy Advisor in London where he was instrumental in developing the company’s entry strategy into emerging markets in Asia, Latin America and Eastern Europe. Mr. Teo is qualified in accounting from the UK ACCA, and is a graduate of Trinity College at Cambridge University and the Stanford Business School where he was also an Alfred P. Sloan Fellow.

Mr. Sems, the President of Capital Edge LLC has over ten years of investment management, hedge funds and equity research experience specializing in small cap opportunities. Sems builds upon his core investment philosophy: a conservative value approach to growth and building a long term equity-value in a company.

“We are very serious about Herborium growth opportunities and truly excited to welcome new talents with proven expertise in financial and growth strategies“, said Dr. Agnes P. Olszewski, president and CEO of Herborium. Olszewski added, “We expect to turn accomplishments of our new colleagues into an increase shareholder value for the company.”

This release and oral statements made from time to time by the Company's representatives concerning the same subject matter may contain "forward looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements can be identified by introductory words such as "expects," "plans," "intends," "believes," "will," "estimates," "forecasts," or words of similar meaning, and by the fact that they do not relate strictly to historical or current facts. Many factors may cause actual results to differ from forward-looking statements, including inaccurate assumptions and a broad variety of risks and uncertainties, some of which are known and others of which are not. Known risks and uncertainties include those identified from time to time in the reports filed by the Company with the SEC, which should be considered together with any forward-looking statement. No forward-looking statement is a guarantee of future results or events, and one should avoid placing undue reliance on such statements.